Observational studyCancer chemotherapy and pharmacology2023

Cytidine deaminase enzyme activity is a predictive biomarker in gemcitabine-treated cancer patients.

Alireza Abbaspour et al.PubMed ↗Publisher ↗

No numbers read from the abstract.